Current status of the diagnosis and treatment of Duchenne muscular dystrophy and emerging therapeutic advances
10.19845/j.cnki.zfysjjbzz.2025.0079
- VernacularTitle:Duchenne型肌营养不良的诊治现状与新兴治疗
- Author:
Yi DAI
1
Author Information
1. Department of Neurology， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences， Beijing 100730，China
- Publication Type:Journal Article
- Keywords:
Duchenne muscular dystrophy / Diagnosis and differential diagnosis / Corticosteroid therapy / Gene therapy / Multidisciplinary diagnosis and treatment
- From:
Journal of Apoplexy and Nervous Diseases
2025;42(5):414-418
- CountryChina
- Language:Chinese
-
Abstract:
Duchenne muscular dystrophy is the most common genetic neuromuscular disease and is also a severely disabling and fatal disease that seriously harms the health of children. Treatment regimens are rapidly advancing with a gradually deeper understanding of the disease. This article introduces the etiology， pathogenesis， clinical manifestations， auxiliary examinations， diagnosis， and differential diagnosis of the disease， with a focus on the advances in the treatment of Duchenne muscular dystrophy in recent years， in order to enhance the management skills of neurologists， pediatricians， and other related specialists.
- Full text:2025071616045890768Duchenne型肌营养不良的诊治现状与新兴治疗.pdf
